AlanGWynneMD

Endocrinology • Topeka, KS

Diabetes, Osteoporosis & Bone Metabolism Medicine, Pituitary Disorders & Neuroendocrinology, Thyroid

Endocrinologist at the Cotton-O'Neil Clinic in Topeka, KS

Join to view full profile

Dr. Wynne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wynne's full profile

Already have an account?

Office
3520 SW 6th Ave
Topeka, KS 66606
Phone+1 785-368-9591

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1991
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1985 - 1988
University of Missouri-Columbia School of MedicineClass of 1985

Certifications & Licensure

KS State Medical License 1991 - 2025
MN State Medical License 1986 - 1991
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012

Clinical Trials

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
Completed
Phase 3
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2014 Feb 01
Terminated
Phase 4
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes Start of enrollment: 2014 Apr 01
Completed
Phase 2
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Completed
Not Applicable
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
Completed
Phase 3
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy Start of enrollment: 2016 Dec 01
Completed
Phase 2
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2017 May 24
Completed
Phase 2
A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes. Start of enrollment: 2020 Apr 30
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

239 citations
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 tr...
Stefano Del Prato, Steven E. Kahn, Imre Pavo, Govinda Weerakkody, Zhengyu Yang
Lancet. 2021-11-13
169 citations
THE GLUCAGONOMA SYNDROME : CLINICAL AND PATHOLOGIC FEATURES IN 21 PATIENTS
Robert A. Wermers, Vahab Fatourechi, Alan G. Wynne, Larry K. Kvols, Ricardo V. Lloyd
Medicine. 1996-03-01
29 citations
Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo-controlled trial in patients with type 2 diabetes using metformin.
Juan P. Frias, Alan G. Wynne, Beata Matyjaszek-Matuszek, Dagmar Bartaskova, David A. Cox
Diabetes, Obesity & Metabolism. 2019-09-01

Press Mentions

Can Your Apple Watch Diagnose Thyroid Issues?April 16th, 2018
'It Saved My Life': How a Smartwatch Stopped a Woman's Health CrisisApril 12th, 2018
This Woman's Apple Watch Helped Detect Her Severe Thyroid ProblemApril 12th, 2018